Nitin Tandon Selected Research

Drug Therapy (Chemotherapy)

5/2021	PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
1/2020	Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation.
1/2020	NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nitin Tandon Research Topics

Disease

11	Neoplasms (Cancer) 07/2021 - 08/2013
10	Epilepsy (Aura) 12/2022 - 02/2010
6	Glioblastoma (Glioblastoma Multiforme) 05/2021 - 08/2017
3	Temporal Lobe Epilepsy 01/2021 - 01/2018
3	Glioma (Gliomas) 12/2020 - 08/2013
3	Brain Neoplasms (Brain Tumor) 01/2020 - 08/2013
3	Partial Epilepsies (Epilepsy, Partial) 01/2018 - 12/2016
2	COVID-19 01/2022 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 11/2018
2	Periventricular Nodular Heterotopia 10/2016 - 03/2014
1	Generalized Epilepsy 01/2022
1	Hematoma 12/2020
1	Necrosis 01/2019
1	Meningioma (Meningiomas) 11/2018
1	Hippocampal Sclerosis 01/2018
1	Anomia (Dysnomia) 01/2018
1	Optic Neuritis (Retrobulbar Neuritis) 08/2017
1	Drug Resistant Epilepsy 01/2017
1	Epileptic Syndromes 12/2016
1	Penetrating Head Injuries (Penetrating Head Injury) 04/2016
1	Meningitis 04/2016
1	Hydrocephalus (Hydrocephaly) 01/2013
1	Rupture 01/2013
1	Aseptic Meningitis 01/2013

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
3	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 01/2020
2	mesoglycanIBA 12/2022 - 01/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	IndazolesIBA 07/2021
1	Protein Kinase InhibitorsIBA 07/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2021
1	Therapeutic UsesIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 07/2019
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 02/2019
1	Opiate AlkaloidsIBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Carboxylic AcidsIBA 11/2018
1	fluciclovine F-18IBA 11/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2018
1	N 30IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	Intercalating AgentsIBA 10/2017
1	NaphthalimidesIBA 10/2017
1	ZincIBA 08/2013
1	SteroidsIBA 01/2013
1	Amobarbital (Amsal)IBA 02/2010

Therapy/Procedure

8	Therapeutics 05/2021 - 10/2017
5	Laser Therapy (Surgery, Laser) 01/2021 - 03/2014
4	Lasers (Laser) 01/2021 - 08/2017
4	Electrodes (Electrode) 12/2020 - 12/2016
3	Drug Therapy (Chemotherapy) 05/2021 - 01/2020
2	Deep Brain Stimulation 12/2022 - 01/2022
2	Radiotherapy 03/2021 - 01/2019
2	Operative Surgical Procedures 09/2019 - 01/2019
2	Implanted Electrodes 07/2018 - 05/2013
1	Radiofrequency Ablation 01/2021
1	Craniotomy 12/2020
1	Anterior Temporal Lobectomy 01/2020
1	Cytoreduction Surgical Procedures 08/2017
1	Neurosurgical Procedures 04/2016
1	Perioperative Period 01/2013